Skip to main content
Erschienen in: World Journal of Surgery 2/2007

01.02.2007

Safety and Efficacy of Surgical Management of Hyperthyroidism: 15-year Experience from a Tertiary Care Center in a Developing Country

verfasst von: P. V. Pradeep, MS, DNB, MRCSEd, Amit Agarwal, MS, Mukta Baxi, MS, Gaurav Agarwal, MS, PDCC, Sushil Kumar Gupta, MD, DM, S. K. Mishra, MS, DNB, FACS

Erschienen in: World Journal of Surgery | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Ideal management of toxic goiter still remains elusive. Though surgical management of toxic multinodular goiter (MNG) is well accepted, surgical treatment of Graves’ disease (GD) is still controversial in view of the presumed increased incidence of complications. In this paper, we discuss the experience of the surgical management of hyperthyroidism at a specialized tertiary care endocrine center in a developing country, highlighting the minimal morbidity and satisfactory outcome in experienced hands.

Materials and methods

We retrospectively reviewed 325 consecutive patients with hyperthyroidism managed surgically from 1990 to 2005. The etiologic diagnoses were Graves’ disease (185), toxic MNG (105), and autonomously functioning thyroid nodules (AFTN) (n = 35). The indications for surgery in Graves’ patients were large goiter, relapse after antithyroid drug therapy (ATD), Graves’ ophthalmopathy, and presence of nodule. The indications for surgery in toxic MNG were retrosternal extension (n = 15), compressive symptoms (n = 20), and large size (grade II). Among the AFTN nodule size, those greater than 4 cm (85%) formed the major indication for surgery. Subjects with GD and toxic MNG were subjected to subtotal thyroidectomy (n = 93 prior to 1995) or total thyroidectomy (n = 205 post-1995). Hemithyroidectomy was the procedure of choice in patients with AFTN.

Results

Patients with Graves’ disease were younger in age, with shorter mean duration of goiter when compared with the other 2 groups. Eight percent of patients with Graves’ disease without a clinically palpable nodule and 25% of those with nodules had associated differentiated carcinoma, including papillary, follicular, and medullary thyroid cancer. Four percent of patients with toxic MNG had malignancy. Complications included temporary hypocalcemia (24%), permanent hypocalcemia (3%), and permanent vocal-cord palsy (1%).

Conclusions

Surgery for hyperthyroidism has negligible mortality and acceptable morbidity in experienced hands. It is a definite option in selected cases. Immediate and permanent cure of hyperthyroidism is achieved, with no recurrences, after total thyroidectomy. The cosmetic outcome is good, with excellent patient satisfaction and acceptance.
Literatur
1.
Zurück zum Zitat Franklyn J, Sheppard M. Radioiodine for hyperthyroidism. BMJ 1992;305:727–728PubMed Franklyn J, Sheppard M. Radioiodine for hyperthyroidism. BMJ 1992;305:727–728PubMed
2.
Zurück zum Zitat Pierce EN, Breaverman LE. Hyperthyroidism: advantages and disadvantages of medical therapy. Surg Clin N Am 2004; 84:833–847CrossRef Pierce EN, Breaverman LE. Hyperthyroidism: advantages and disadvantages of medical therapy. Surg Clin N Am 2004; 84:833–847CrossRef
3.
Zurück zum Zitat Reid R, Stephen F Wheeler. Hyperthyroidism: diagnosis and treatment, Am Fam Physician 2005;72:623–630 Reid R, Stephen F Wheeler. Hyperthyroidism: diagnosis and treatment, Am Fam Physician 2005;72:623–630
4.
Zurück zum Zitat Linos DA, Karakitsos D, Papademetriou J. Should the primary treatment of hyperthyroidism be surgical. Eur J Surg 1997;163:651–657PubMed Linos DA, Karakitsos D, Papademetriou J. Should the primary treatment of hyperthyroidism be surgical. Eur J Surg 1997;163:651–657PubMed
5.
Zurück zum Zitat Weber KJ, Solorzano CC, Lee JK, et al. Thyroidectomy remains an effective treatment option for Graves’ disease. Am J Surg. 2006 191(3):400–405PubMedCrossRef Weber KJ, Solorzano CC, Lee JK, et al. Thyroidectomy remains an effective treatment option for Graves’ disease. Am J Surg. 2006 191(3):400–405PubMedCrossRef
6.
Zurück zum Zitat Lal G, Ituarte P, Kebebew E, et al. Should total thyroidectomy become the preferred procedure for surgical management of Graves’ disease? Thyroid. 2005 15(6):569–574PubMedCrossRef Lal G, Ituarte P, Kebebew E, et al. Should total thyroidectomy become the preferred procedure for surgical management of Graves’ disease? Thyroid. 2005 15(6):569–574PubMedCrossRef
7.
Zurück zum Zitat Boger MS, Perrier ND. Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin N Am 2004;84:849–874PubMedCrossRef Boger MS, Perrier ND. Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin N Am 2004;84:849–874PubMedCrossRef
8.
Zurück zum Zitat Harada T, Shimaouka K, Mimura T, et al. Current treatment of Graves disease. Surg Clin North Am 1987;67:299–314PubMed Harada T, Shimaouka K, Mimura T, et al. Current treatment of Graves disease. Surg Clin North Am 1987;67:299–314PubMed
9.
Zurück zum Zitat Erickson D, Gharib H, Li H, et al. Treatment of patients with toxic multinodular goiter. Thyroid 1998;8 (4):277–280PubMedCrossRef Erickson D, Gharib H, Li H, et al. Treatment of patients with toxic multinodular goiter. Thyroid 1998;8 (4):277–280PubMedCrossRef
10.
Zurück zum Zitat Mishra A, Agarwal G, Agarwal A, et al. Safety and efficacy of total thyroidectomy in hands of endocrine surgery trainees. Am J Surg. 1999;178(5):377–380PubMedCrossRef Mishra A, Agarwal G, Agarwal A, et al. Safety and efficacy of total thyroidectomy in hands of endocrine surgery trainees. Am J Surg. 1999;178(5):377–380PubMedCrossRef
11.
Zurück zum Zitat Acun Z, Cihan A, Ulukent SC, et al. A randomized prospective study of complications between general surgery residents and attending surgeons in near-total thyroidectomies. Surg Today. 2004;34(12):997–1001PubMedCrossRef Acun Z, Cihan A, Ulukent SC, et al. A randomized prospective study of complications between general surgery residents and attending surgeons in near-total thyroidectomies. Surg Today. 2004;34(12):997–1001PubMedCrossRef
12.
Zurück zum Zitat Barakate MS, Agarwal G, Reeve TS, et al. Total Thyroidectomy is now the preferred option for the surgical management of Graves disease. ANZ J Surg 2002;72:321–324PubMedCrossRef Barakate MS, Agarwal G, Reeve TS, et al. Total Thyroidectomy is now the preferred option for the surgical management of Graves disease. ANZ J Surg 2002;72:321–324PubMedCrossRef
13.
Zurück zum Zitat Thakur S, Sharma AK, Agarwal A, et al. Carcinoma in Graves Disease. J Assoc of Physicians of India 1995;43(9):600–601 Thakur S, Sharma AK, Agarwal A, et al. Carcinoma in Graves Disease. J Assoc of Physicians of India 1995;43(9):600–601
14.
Zurück zum Zitat Kraimps JL, Bouin-Pineau MH, Mathonnet M, et al. Multicenter study of thyroid nodules in patients with Graves disease. Br J Surg 2000;87:1111–1113PubMedCrossRef Kraimps JL, Bouin-Pineau MH, Mathonnet M, et al. Multicenter study of thyroid nodules in patients with Graves disease. Br J Surg 2000;87:1111–1113PubMedCrossRef
15.
Zurück zum Zitat Carnell NE, Valente WA. Thyroid nodules in Graves disease: classification, characterization, and response to treatment. Thyroid 1998;8:647–652PubMed Carnell NE, Valente WA. Thyroid nodules in Graves disease: classification, characterization, and response to treatment. Thyroid 1998;8:647–652PubMed
16.
Zurück zum Zitat Mishra A, Mishra S. Thyroid nodules in Graves’ disease: implications in an endemically iodine deficient area. J Postgrad Med 2001;47(4):244–247PubMed Mishra A, Mishra S. Thyroid nodules in Graves’ disease: implications in an endemically iodine deficient area. J Postgrad Med 2001;47(4):244–247PubMed
17.
Zurück zum Zitat Agarwal A, Mishra SK. Role of surgery in management of Graves disease. J Indian Med Assoc 2001;99(5):253–256 Agarwal A, Mishra SK. Role of surgery in management of Graves disease. J Indian Med Assoc 2001;99(5):253–256
18.
Zurück zum Zitat Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 2001;25:307–310PubMedCrossRef Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 2001;25:307–310PubMedCrossRef
19.
20.
Zurück zum Zitat Bartlena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocrine Reviews 2000;21(2):168–199CrossRef Bartlena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocrine Reviews 2000;21(2):168–199CrossRef
21.
Zurück zum Zitat Fernandez-Sanchez JR, Rosal Pradas J, Carazo Martinez O, et al. Graves’ ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80:1134–1136 Fernandez-Sanchez JR, Rosal Pradas J, Carazo Martinez O, et al. Graves’ ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80:1134–1136
22.
Zurück zum Zitat Winsa B, Rastad J, Akerstrom G, et al. Retrospective evaluation of subtotal and total thyroidectomy in Graves’ disease with or without ophthalmopathy. Eur J Endocrinol 1995;132:406–412PubMedCrossRef Winsa B, Rastad J, Akerstrom G, et al. Retrospective evaluation of subtotal and total thyroidectomy in Graves’ disease with or without ophthalmopathy. Eur J Endocrinol 1995;132:406–412PubMedCrossRef
23.
Zurück zum Zitat Tallstedt L, Lundell G, Torring O, et al. and the thyroid study group. Occurrence of ophthalmopathy after treatment for Graves hyperthyroidism. N Eng J Med 1992;326:1733–1738CrossRef Tallstedt L, Lundell G, Torring O, et al. and the thyroid study group. Occurrence of ophthalmopathy after treatment for Graves hyperthyroidism. N Eng J Med 1992;326:1733–1738CrossRef
Metadaten
Titel
Safety and Efficacy of Surgical Management of Hyperthyroidism: 15-year Experience from a Tertiary Care Center in a Developing Country
verfasst von
P. V. Pradeep, MS, DNB, MRCSEd
Amit Agarwal, MS
Mukta Baxi, MS
Gaurav Agarwal, MS, PDCC
Sushil Kumar Gupta, MD, DM
S. K. Mishra, MS, DNB, FACS
Publikationsdatum
01.02.2007
Erschienen in
World Journal of Surgery / Ausgabe 2/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-006-0572-9

Weitere Artikel der Ausgabe 2/2007

World Journal of Surgery 2/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.